Cargando…
Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications
In the present study, a nanoapatite-mediated delivery system for imatinib has been proposed. Nanohydroxyapatite (nHAp) was obtained by co-precipitation method, and its physicochemical properties in combination with imatinib (IM) were studied by means of XRPD (X-ray Powder Diffraction), SEM-EDS (Scan...
Autores principales: | Sobierajska, Paulina, Serwotka-Suszczak, Anna, Szymanski, Damian, Marycz, Krzysztof, Wiglusz, Rafal J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587182/ https://www.ncbi.nlm.nih.gov/pubmed/33050306 http://dx.doi.org/10.3390/molecules25204602 |
Ejemplares similares
-
Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform—Physicochemical Properties and In Vitro Studies on Mastocytoma Cells
por: Sobierajska, Paulina, et al.
Publicado: (2022) -
Imatinib-Functionalized
Galactose Hydrogels Loaded
with Nanohydroxyapatite as a Drug Delivery System for Osteosarcoma:
In Vitro Studies
por: Sobierajska, Paulina, et al.
Publicado: (2023) -
Aminopropyltriethoxysilane (APTES)-Modified Nanohydroxyapatite (nHAp) Incorporated with Iron Oxide (IO) Nanoparticles Promotes Early Osteogenesis, Reduces Inflammation and Inhibits Osteoclast Activity
por: Marycz, Krzysztof, et al.
Publicado: (2022) -
Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1
por: Marycz, Krzysztof, et al.
Publicado: (2021) -
Nanohydroxyapatite as a Biomaterial for Peripheral Nerve Regeneration after Mechanical Damage—In Vitro Study
por: Wiatrak, Benita, et al.
Publicado: (2021)